LiveRamp Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LiveRamp Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	880	917	286	381	443	529	597	660	746	813
Cost of revenue	100	96.4	121	153	144	147	170	179	216	238
Gross profit	74.8	124	165	228	299	381	426	480	530	575
Research and development	49.4	60.7	85.7	106	135	158	189	151	177	148
Selling and marketing	59.3	109	159	189	178	183	202	196	213	206
General and administrative	92.9	85.2	98.9	109	104	105	125	110	126	133
Operating expenses	206	257	363	409	420	447	552	469	524	491
Operating income	-131	-134	-198	-181	-121	-65.5	-126	11.4	5.4	83.5
Interest expense	7.38	10.1
Other non-operating income	0.65	0.5	18.8	15.4	-0.25	30.5	6.95	23	17.4	14.6
Pre-tax income	-131	-133	-179	-166	-121	-35.1	-119	34.4	22.8	98.1
Income tax	-45.2	-65.7	-45.4	-40.3	-30.5	-1.24	5.25	24.3	25.3	-46.7
Income from continuing operations	-85.6	-67.3	-134	-125	-90.3	-33.8	-124	10.1	-2.5	145
Net income	4.11	23.5	1,029	-125	-90.3	-33.8	-119	11.9	-0.81	146
EBITDA	-99.4	-95.9	-164	-145	-92.8	-41.3	-105	22.9	22.6	96.9
EPS, basic	0.05	0.30	13.71	-1.84	-1.36	-0.50	-1.79	0.18	-0.01	2.28
EPS, diluted	0.05	0.30	13.71	-1.84	-1.36	-0.50	-1.79	0.17	-0.01	2.24
Shares, basic (weighted)	77.6	78.9	75	67.8	66.3	68.2	66.4	66.3	66.1	64.1
Shares, diluted (weighted)	77.6	78.9	75	67.8	66.3	68.2	66.4	67.9	66.1	65

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	169	140	1,061	718	573	600	464	337	413	380
Short-term investments						7.5	32.8	32	7.5	7.5
Receivables	143	52	78.6	92.8	114	148	157	190	186	213
Other current assets	48.3	20.2	44.2	32.7	64.1	29.5	31	31.7	38.9	42.9
Total current assets	369	361	1,192	896	826	816	715	602	656	653
Property, plant and equipment	156	32.3	26	19.3	12	11.5	7.09	8.18	6.18	5.15
Lease right-of-use assets			0	17.8	11.7	59.5	24.6	24.5	19.3	16.2
Goodwill	200	204	205	298	357	364	363	502	502	502
Intangible assets	66.3	44.5	28.6	45.2	39.7	26.7	9.87	34.6	20.2	9.17
Other non-current assets	51.4	37.9	10.8	27.2	30.9	85.2	41	36.7	28.6	26.1
Total assets	1,235	1,209	1,473	1,302	1,288	1,334	1,173	1,231	1,259	1,294
Accounts payable	40.2	18.8	31.2	42.2	40	83.2	86.6	81.2	112	130
Accrued liabilities	53.2	13.8	18.7	28.8	46.4	39.2	33.4	61.6	50.8	55.1
Deferred revenue	37.1	4.51	4.28	6.58	11.6	16.1	19.1	30.9	45.9	39.7
Short-term debt	39.8	1.58	0
Total current liabilities	230	179	95.1	161	165	185	175	217	248	265
Long-term debt	189	228	0
Lease liabilities				11.4	4.16	52.2	37.2	32.1	26.9	19.9
Other non-current liabilities	17.7	10	47	53	42.4	86.1	71.8	65.7	63	57.4
Total liabilities	496	460	142	214	208	271	247	282	311	322
Total debt	39.8	1.58	0
Paid-in capital	1,154	1,236	1,407	1,497	1,630	1,721	1,856	1,934	2,045	2,130
Retained earnings	603	628	1,670	1,545	1,455	1,421	1,302	1,314	1,313	1,459
Treasury stock	-1,039	-1,139	-1,768	-1,974	-2,027	-2,100	-2,252	-2,318	-2,430	-2,639
Other comprehensive income	8	10.8	7.8	5.75	7.52	5.73	4.5	3.96	4.3	5.64
Shareholders' equity	739	749	1,331	1,088	1,081	1,063	926	949	949	972
Total equity	739	749	1,331	1,088	1,081	1,063	926	949	949	972
Total liabilities and equity	1,235	1,209	1,473	1,302	1,288	1,334	1,173	1,231	1,259	1,294

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	4.11	23.5	1,029	-125	-90.3	-33.8	-119	11.9	-0.81	146
Depreciation and amortization	32	37.6	33.8	35.9	27.7	24.2	20.8	11.5	17.2	13.4
Stock-based compensation	39.4	52.9	103	89.4	112	87.3	126	71.3	108	83
Deferred income tax	-11.1	-27.8	9.89	-6.88	-1.42	-1.54	0.12	-0.46	-0.45	-56.3
Change in receivables	-10.1	-13.7	-44.4	-20.5	-24.8	-38.6	-12.1	-32.3	3.55	-28.3
Change in payables	0.81	-3.22	25.3	24.9	-0.12	8.85	-15.4	8.51	3.57	3.02
Cash from operations	-25.9	-14.1	-1.98	-28.6	-20.6	78.1	34.4	106	154	168
Capital expenditures	-23.1	-9.38	-7.32	-11.7	-2.18	-4.5	-4.7	-4.26	-1.04	-1.38
Acquisitions	-137	-4.48	0	-105	-76	-19.1	0	-170	-1.95	-0.6
Purchases of investments			0	0	-7.5	0	-28.2	-48.9	-1.97	0
Sales and maturities of investments					0	0	1.39	0	0.76	0.36
Cash from investing	-124	-14.1	-11.1	-116	-87.9	7.58	-29	-174	21.4	-4.93
Debt issued	70	230	0	0
Debt repaid	-32.2	-227	-233	0	0
Stock issued	21.1	19.7	20.4	4.74	8.74	6.27	6.26	7.22	8.83	8.21
Share buybacks	-30.5	-88.9	-74.4	-182	-42.3	-58.6	-150	-60.5	-101	-195
Cash from financing	25.8	-81.5	-842	-202	-43.5	-67	-146	-59.1	-103	-199
Exchange rate effect		1.44	-1.75	-0.47	1.01	-0.2	-0.55	0.37	0.11	0.97
Net change in cash	-20	-28.7	921	-329	-151	18.5	-136	-125	74.5	-34.4
Free cash flow	-49	-23.5	-9.3	-40.3	-22.7	73.6	29.7	101	153	166
Interest paid	7.78	9.17
Income taxes paid	-6.87	-1.24	440	-7.34	-2.91	-32.9	5.8	-0.3	20.1	2.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $37.50 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	70.8%	Gross profit / revenue.
Operating margin	11.6%	Operating income / revenue.
EBITDA margin	13.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	13.3%	Pre-tax income / revenue.
Net margin	18.7%	Net income / revenue.
Effective tax rate	-40.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.2%	Net income / average total assets.
Return on invested capital (ROIC)	12.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	17.5%	Research and development expense / revenue.
Stock-based pay / revenue	9.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.2%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	9.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	10.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	10.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	14.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	1,445.0%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	328.4%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	9.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	69.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	8.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	77.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	2.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-2.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.66x	Current assets / current liabilities.
Quick ratio	2.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.55x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	23.6%	Total liabilities / total assets.
Working capital	$396.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	39.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$469.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.65x	Revenue / average total assets.
Fixed asset turnover	155x	Revenue / average property, plant and equipment.
Receivables turnover	3.84x	Revenue / average receivables.
Days sales outstanding	95 days	365 x average receivables / revenue.
Days payables	193 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.52	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$13.45	Revenue / diluted weighted shares.
Book value per share	$15.80	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.58	Tangible book value / shares outstanding.
Cash per share	$6.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.28B	Share price x shares outstanding.
Enterprise value	$1.91B	Market cap + total debt - cash - short-term investments.
P/E	14.6x	Market cap / net income. Only when net income is positive.
P/S	2.74x	Market cap / revenue.
P/B	2.33x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.86x	Market cap / tangible book value, when positive.
EV/Sales	2.29x	Enterprise value / revenue.
EV/EBIT	19.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.4x	Enterprise value / EBITDA, when both are positive.
Earnings yield	6.8%	Net income / market cap (the inverse of P/E).
Shareholder yield	8.0%	(Dividends paid + share buybacks) / market cap.

What was LiveRamp Holdings, Inc.'s revenue in fiscal 2026?

LiveRamp Holdings, Inc. reported revenue of $812.9M for fiscal 2026, 9% higher than the year before.

Was LiveRamp Holdings, Inc. profitable in fiscal 2026?

Yes. Net income was $146.0M, a net margin of 18%.

How much free cash flow did LiveRamp Holdings, Inc. generate in fiscal 2026?

Cash from operations of $167.8M minus capital expenditures of $1.4M left free cash flow of $166.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LiveRamp Holdings, Inc.